Sunesis Pharmaceuticals

About:

Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.

Website: http://www.sunesis.com

Top Investors: Warburg Pincus, Biogen, New Enterprise Associates, Mayfield Fund, Venrock

Description:

Sunesis is an emerging biopharmaceutical company creating new medicines to improve the lives of people with cancer. They are building a pipeline of drugs that selectively block critical mechanisms required for tumor growth and survival. The fight against cancer is an enormous mission that requires an integrated approach fueled by a commitment to innovation.

Total Funding Amount:

$222M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

1998-01-01

Contact Email:

info(AT)sunesis.com

Founders:

James Wells

Number of Employees:

51-100

Last Funding Date:

2016-10-19

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai